Target intelligence / Profile preview

STEAP3 antisense RNA 1 (STEAP3-AS1)

Target
STEAP3-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Other
01

Overview

STEAP3 antisense RNA 1 (STEAP3-AS1) is a long noncoding RNA located antisense to the STEAP3 gene. It is upregulated in colon and colorectal cancer tissues and cell lines and is associated with poor prognosis in these cancers[1][2][3]. STEAP3-AS1 exerts its bioactivity by modulating the expression and stability of the neighboring STEAP3 gene, which encodes an iron transporter. Mechanistically, STEAP3-AS1 can regulate cell proliferation, cell cycle, and cell migration by affecting downstream molecular pathways, including CDKN1C and Wnt/β-catenin signaling[1][2][3]. Under hypoxic conditions, HIF-1α increases the transcription of STEAP3-AS1, which then competitively binds the RNA-binding protein YTHDF2, stabilizing STEAP3 mRNA and promoting iron metabolism and Wnt/β-catenin signaling activation, thus contributing to cancer progression[2][3]. Knockdown of STEAP3-AS1 suppresses tumor growth, highlighting its therapeutic relevance as a molecular marker and a potential, although not yet direct, target in colorectal cancer research[1][2].

Other names
STEAP3-AS1STEAP3 antisense RNA 1 (non-protein coding)
02

Biological functions

Cell proliferationCell migrationCell cycle regulationRegulation of gene expression (specifically STEAP3 and CDKN1C)Modulation of Wnt/β-catenin signaling pathwayIron metabolism (via regulation of STEAP3 protein)
03

Disease associations

Cancer (especially colorectal cancer and colon cancer)Tumor progression
04

Biomarkers

STEAP3-AS1 expression is suggested as a biomarker for poor prognosis in colorectal cancer

Beyond the preview

Go deeper on STEAP3 antisense RNA 1 (STEAP3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STEAP3 antisense RNA 1 (STEAP3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call